Age-Dependent Differences in Canakinumab Safety: A Comprehensive Pharmacovigilance Analysis Using the FAERS Database
{{output}}
While the efficacy of canakinumab, an anti-interleukin-1β monoclonal antibody, is well-established, its safety profile, particularly across different age groups, remains inadequately explored. Using the FDA Adverse Event Reporting System (FAERS) database, thi... ...
